首页> 外文期刊>Clinical and experimental hypertension: CEH >Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
【24h】

Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.

机译:纤溶酶原激活物抑制剂1和昼夜节律在代谢性疾病中。

获取原文
获取原文并翻译 | 示例
           

摘要

Plasma PAI-1 levels robustly fluctuate in a circadian manner and consequently contribute to hypofibrinolysis during the early morning. The circadian expression of PAI-1 gene is thought to be directly regulated by the circadian clock proteins such as CLOCK and BMAL1/BMAL2 which drive the endogenous biological clock. Plasma PAI-1 levels are increased in the beginning of the active phase in both diurnal humans and in nocturnal rodents, suggesting that the rhythmic PAI-1 expression is commonly indispensable for organisms. A series of our recent studies revealed that circadian clock proteins are important for hypofibrinolysis induced by metabolic disorders such as obesity and diabetes.
机译:血浆PAI-1水平以昼夜节律的方式剧烈波动,因此在清晨有助于纤维蛋白溶解降低。 PAI-1基因的昼夜节律表达被认为直接受昼夜节律蛋白例如CLOCK和BMAL1 / BMAL2的驱动,这些蛋白驱动内源性生物钟。在昼夜人和夜间啮齿动物中,活动期开始时血浆PAI-1的水平都会升高,这表明节律性PAI-1的表达通常对于生物体是必不可少的。我们最近的一系列研究表明,昼夜节律钟蛋白对于由肥胖症和糖尿病等代谢性疾病引起的纤溶不足很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号